Cosmos Health Inc. (COSM)
(Delayed Data from NSDQ)
$0.66 USD
-0.02 (-2.28%)
Updated Jun 14, 2024 03:51 PM ET
After-Market: $0.65 -0.01 (-1.50%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
COSM 0.66 -0.02(-2.28%)
Will COSM be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for COSM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COSM
MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates
Pyxis Oncology, Inc. (PYXS) Reports Q1 Loss, Tops Revenue Estimates
COSM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Tops Revenue Estimates
Other News for COSM
Cosmos Holdings completes acquisition of Pelofarm's distribution network
Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million
GPRO, IRBT among notable consumer discretionary additions to Russell Microcap; PLBY, RMCF out
Medifast, Beauty Health among consumer staples additions in Russell Microcap; PLBY Group, Rocky Mountain Chocolate removed
12 Health Care Stocks Moving In Thursday's After-Market Session